MiniMed Group Inc.
MMED | NASDAQ
$18.77
+$0.49 (+2.68%)
Nov 2, 2026, 1:39 PM ET · Market open
Market Data
Market Cap $5.28B
Enterprise Value $5B
Beta -3.71
Average Volume 5.5M
Shares Outstanding (Diluted) 281M
Shares Change YoY N/A
Institutional Ownership 13.98%
Exchange NASDAQ
ISIN US60365F1093
Price Performance
Price Change 1M -4.7%
Price Change 3M -1.7%
Price Change 6M 58.1%
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -16.1%
1Y CAGR (ann.) N/A
5Y CAGR (ann.) N/A
All-Time CAGR -1.7%
Valuation
PE Ratio -16.62
Forward PE 29.27
PEG Ratio 0.15
Forward PEG -0.14
PS Ratio 1.60
Forward PS 1.50
PB Ratio 1.42
P/FCF Ratio -16.28
P/Adj. FCF Ratio -14.17
P/OCF Ratio -49.41
EV/Sales 1.55
EV/EBIT 454.10
EV/EBITDA 56.12
EV/FCF -15.81
Earnings Yield -6.0%
FCF Yield -6.1%
Adj. FCF Yield -7.1%
Financial Health
Net Cash $207M
Total Debt $59M
Cash & Short-Term Investments $207M
Total Assets $4.72B
Current Ratio 1.81
Quick Ratio 1.36
Debt / Equity Ratio 0.02
Debt / EBITDA 0.66
Debt / FCF -0.19
OCF / Debt -1.78
Interest Coverage 0.00
Altman Z-Score 3.63
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 53.9%
Operating Profit Margin 0.5%
EBITDA Margin 5.3%
Net Profit Margin -10.2%
FCF Margin -9.8%
Adj. FCF Margin -11.3%
SBC / Revenue 1.5%
SBC Impact (per share) -14.9%
Returns
Return on Assets -7.0%
Return on Equity -9.1%
Return on Invested Capital 0.4%
Return on Capital Employed 0.4%
Return on Tangible Assets -13.9%
Historical Growth (CAGR)
Revenue CAGR 3Y 11.4%
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -51.7%
EPS CAGR 5Y N/A
EPS CAGR 10Y N/A
FCF CAGR 3Y -81.0%
FCF CAGR 5Y N/A
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 8
EPS Growth Next 3Y 84.8%
Revenue Growth Next 3Y 8.3%
Earnings Date Dec 30, 2026
EPS Estimate (next Q) $0.12
EPS Growth Est (next Q) N/A
Revenue Est (next Q) $825.2M
Revenue Growth Est (next Q) 9.7%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $25.73
Price Target Upside 40.8%
Cash Flow
Operating Cash Flow $-105M
Free Cash Flow $-316M
Adj. Free Cash Flow $-363M
FCF Per Share -$1.12
OCF Per Share -$0.37
OCF/S Ratio -3.3%
Income Statement
Revenue $3.22B
Gross Profit $1.74B
Operating Income $17M
EBITDA $89M
Net Income $-329M
EPS (Diluted) -$1.10
Revenue / Employee $402.75K
Profit / Employee $-41.13K
Employees 8,000
Add to Watchlist
Select watchlists to add or remove MMED